Proportion of isolates with resistance to azithromycin reported to in Belgium
Belgium: Proportion of isolates with resistance to azithromycin reported to was 17.6 in 2020. ◆ Volatile
Proportion of isolates with resistance to azithromycin reported to in Belgium, 2009–2020
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with resistance to azithromycin reported to in Belgium is 17.6, measured in 2020. That is the highest value across all 11 years on record.
Compared with earlier readings it is up 22.2% on the previous year and up 545.3% over ten years.
Over the whole period, proportion of isolates with resistance to azithromycin reported to in Belgium peaked at 17.6 in 2020 and was at its lowest, 1.82, in 2013.
Belgium ranks 7th of 47 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with resistance to azithromycin reported to in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 14.55 | — |
| 2010 | 2.73 | -81.3% |
| 2011 | 3.64 | +33.3% |
| 2012 | 1.87 | -48.6% |
| 2013 | 1.82 | -2.7% |
| 2014 | 3.57 | +96.4% |
| 2015 | 3.03 | -15.2% |
| 2016 | 9.09 | +200.0% |
| 2017 | 12.2 | +34.2% |
| 2018 | 14.4 | +18.0% |
| 2020 | 17.6 | +22.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 14.55 | 14.55 | 14.55 | 1 |
| 2010s | 5.82 | 1.82 | 14.4 | 9 |
| 2020s | 17.6 | 17.6 | 17.6 | 1 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Population ages 40-44, male, annual growth rate -0.4409 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0323 units per person (2025)
- Population ages 45-49, female, annual growth rate 1.69 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0319 units per person (2025)
Frequently asked questions
- What is proportion of isolates with resistance to azithromycin reported to in Belgium?
- Proportion of isolates with resistance to azithromycin reported to in Belgium was 17.6 in 2020, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with resistance to azithromycin reported to recorded in Belgium?
- The highest recorded value was 17.6 in 2020.
- What is the lowest proportion of isolates with resistance to azithromycin reported to recorded in Belgium?
- The lowest recorded value was 1.82 in 2013.
- How does Belgium rank for proportion of isolates with resistance to azithromycin reported to?
- Belgium ranks 7th out of 47 countries with data for 2020.
- Is proportion of isolates with resistance to azithromycin reported to rising or falling in Belgium?
- Over the last ten years it is up 545.3%. The long-run trend across the full record is volatile.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).